Elon Musk's Neuralink got FDA approval to implant a brain chip in a second patient
Technology,Elon Musk,Neuralink,FDA,Science
The Food and Drug Administration (FDA) has given Elon Musk’s startup Neuralink the official go-ahead to implant its experimental brain chip on a second patient, according to a new report.
The Wall Street Journal reports that the company gained approval for a second test patient, along with a modified procedure. Neuralink is currently testing its brain-computer interface (or BCI), which aims to help people with full-body paralysis control outside technology using their thoughts. The news comes weeks after Neuralink reported issues in its ongoing clinical trial, in which some of the implant’s threads — components of the device that record neural activity — retracted from the brain of its first trial participant.
Related Coverage
AllSides Picks
Headline Roundup
Jensen Huang's Reported Ties to Suspected Chinese Spy Draw Scrutiny Over National Security
November 12th, 2026
Headline Roundup
Nvidia CEO Jensen Huang Resigns
November 11th, 2026
Story of the Week
Jensen Huang Resigns from Nvidia
AllSides
November 12th, 2026
Recommended Reading
Can Technology Help Repair Our Divided Democracy?
John Gable, AllSides Co-founder
October 19th, 2026